Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
✍ Scribed by Kristin L White; Robert A Vierkant; Catherine M Phelan; Brooke L Fridley; Stephanie Anderson; Keith L Knutson; Joellen M Schildkraut; Julie M Cunningham; Linda E Kelemen; V Shane Pankratz; David N Rider; Mark Liebow; Lynn C Hartmann; Thomas A Sellers; Ellen L Goode
- Book ID
- 115011576
- Publisher
- BioMed Central
- Year
- 2009
- Tongue
- English
- Weight
- 257 KB
- Volume
- 9
- Category
- Article
- ISSN
- 1471-2407
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract During progression of an in situ to an invasive cancer, epithelial cells lose expression of proteins that promote cell–cell contact, and acquire mesenchymal markers, which promote cell migration and invasion. These events bear extensive similarities to the process of epithelial to mesen
DNA repair gene polymorphisms and mutations are known to influence cancer risk. We studied whether polymorphisms in DNA double strand break (DSB) repair genes are associated with epithelial ovarian cancer (EOC) risk. Up to 1,600 cases and 4,241 controls from 4 separate genetic association studies fr